High prevalence of sequence type 131 isolates producing CTX-M-15 among extended-spectrum β-lactamase-producing Escherichia coli strains in northeast Iran

被引:13
|
作者
Moghanni, Marzie [1 ]
Ghazvini, Kiarash [1 ]
Farsiani, Hadi [1 ]
Namaei, Mohammad Hasan [2 ]
Derakhshan, Mohammad [1 ]
Yousefi, Masoud [1 ]
Maragheh, Alimohammad [3 ]
Jamehdar, Saeid Amel [1 ]
机构
[1] Mashhad Univ Med Sci, Antimicrobial Resistance Res Ctr, Azadi Sq,Med Campus, Mashhad 9177948564, Iran
[2] Birjand Univ Med Sci, Infect Dis Res Ctr, Birjand, Iran
[3] Iranian Social Secur Org, Med Lab Basic Sci, Shahrivar Hosp 17, Mashhad, Iran
关键词
Escherichia coli; Sequence type 131; ST131; ESBL; CTX-M-15; Iran; E; COLI; ANTIMICROBIAL RESISTANCE; ST131; MULTIRESISTANT; DISSEMINATION; O25B-ST131;
D O I
10.1016/j.jgar.2018.05.016
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The recent expansion of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli is a worldwide problem. The purpose of this study was to investigate the molecular characteristics of ESBL producing E. coli strains in Mashhad, located in the northeast of Iran. Methods: A total of 455 clinical E. coli isolates were collected at three hospitals in Mashhad between April-September 2015. Antimicrobial susceptibility was determined by the Kirby-Bauer disk diffusion test. The combination disk test was performed for phenotypic detection of ESBLs. PCR was used to screen isolates for ESBL typing. Phylogenetic groups and sequence type 131 (ST131) were determined by multiplex PCR. Results: The prevalence of ESBL-producing E. coli among the collected strains was 51.6% (235/455). Among the 235 ESBL-producing strains, 222 (94.5%) tested positive for CTX-M type, whilst 115 (48.9%), 92 (39.1%) and 21 (8.9%) were positive for TEM, OXA and SHV, respectively. Moreover, CTX-M-15 (94.1%; 209/222) was the most common ESBL among E. coli. Based on multiplex PCR, phylogenetic group B2 was predominant (169/235; 71.9%), followed by D (32/235; 13.6%), A (21/235; 8.9%) and B1 (13/235; 5.5%). ST131 was the predominant clonal group among the phylogenetic group B2 isolates (151/169; 89.3%). Conclusion: The results revealed that an urgent investigation of the source and transmission pathways of the CTX-M-15-62-ST131 E. coli clone is needed to mitigate this emergent public-health problem. (C) 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:74 / 78
页数:5
相关论文
共 50 条
  • [1] High Prevalence of ST131 Isolates Producing CTX-M-15 and CTX-M-14 among Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates from Canada
    Peirano, Gisele
    Richardson, David
    Nigrin, Jana
    McGeer, Allison
    Loo, Vivian
    Toye, Baldwin
    Alfa, Michelle
    Pienaar, Colette
    Kibsey, Pamela
    Pitout, Johann D. D.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (03) : 1327 - 1330
  • [2] Spread of CTX-M-15 Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates through Household Contact and Plasmid Transfer
    Kojima, Yasuko
    Harada, Sohei
    Aoki, Kotaro
    Ishii, Yoshikazu
    Sawa, Tomoka
    Hasegawa, Kei
    Saji, Tsutomu
    Yamaguchi, Keizo
    Tateda, Kazuhiro
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (05) : 1783 - 1785
  • [3] Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals
    Peirano, Gisele
    Costello, Mike
    Pitout, Johann D. D.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (01) : 19 - 23
  • [4] Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15
    Park, Sun Hee
    Byun, Ji-Hyun
    Choi, Su-Mi
    Lee, Dong-Gun
    Kim, Si-Hyun
    Kwon, Jae-Cheol
    Park, Chulmin
    Choi, Jung-Hyun
    Yoo, Jin-Hong
    [J]. BMC INFECTIOUS DISEASES, 2012, 12
  • [5] Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15
    Sun Hee Park
    Ji-Hyun Byun
    Su-Mi Choi
    Dong-Gun Lee
    Si-Hyun Kim
    Jae-Cheol Kwon
    Chulmin Park
    Jung-Hyun Choi
    Jin-Hong Yoo
    [J]. BMC Infectious Diseases, 12
  • [6] Emergence of CTX-M-15 extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in Bosnia and Herzegovina
    Dedeic-Ljubovic, A.
    Hukic, M.
    Pfeifer, Y.
    Witte, W.
    Padilla, E.
    Lopez-Ramis, I.
    Alberti, S.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (02) : 152 - 156
  • [7] In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum β-lactamase
    Shahid, M.
    Singhai, M.
    Malik, A.
    Shukla, M.
    Khan, H. M.
    Shujatullah, F.
    Tahira, F.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (01) : 187 - 188
  • [8] Prevalence of CTX-M-15 Extended-Spectrum β-Lactamase-Producing Salmonella Isolated from Chicken in Korea
    Kim, Sara
    Kang, Hyun-Wol
    Woo, Gun-Jo
    [J]. FOODBORNE PATHOGENS AND DISEASE, 2015, 12 (08) : 661 - 663
  • [9] Epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli among older adults
    Matsubayashi, Sachi
    Kaye, Keith S.
    Farooq, Sameen
    Marchaim, Dror
    Hayakawa, Kayoko
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2015, 43 (11) : 1261 - 1263
  • [10] Extended-spectrum β-lactamase-producing Escherichia coli
    Sloth, Louise B.
    Hargreaves, Sally
    Nellums, Laura B.
    Nielsen, Rikke T.
    Norredam, Marie
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (04): : 405 - 405